肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

《FIGO 2021癌症报告》——外阴癌诊治指南解读

2022-01-02 中国实用妇科与产科杂志

妇科肿瘤外阴癌

外阴癌是一种罕见的好发于绝经后女性的生殖系统恶性肿瘤。目前并未有针对外阴癌的特别筛查方法,降低其发生率最有效的方法是及时治疗与其发生发展相关的外阴癌前病变。

中文标题：

《FIGO 2021癌症报告》——外阴癌诊治指南解读

发布机构：

发布日期：

2022-01-02

简要介绍：

外阴癌是一种罕见的好发于绝经后女性的生殖系统恶性肿瘤。目前并未有针对外阴癌的特别筛查方法,降低其发生率最有效的方法是及时治疗与其发生发展相关的外阴癌前病变。虽然外阴癌可以无症状,但大多数患者会出现外阴瘙痒或疼痛,发现外阴肿块或溃疡。

相关资料下载：
[AttachmentFileName(sort=1, fileName=《FIGO 2021癌症报告》——外阴癌诊治指南解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=475031c00232e02f, title=《FIGO 2021癌症报告》——外阴癌诊治指南解读, enTitle=, guiderFrom=中国实用妇科与产科杂志, authorId=0, author=, summary=外阴癌是一种罕见的好发于绝经后女性的生殖系统恶性肿瘤。目前并未有针对外阴癌的特别筛查方法,降低其发生率最有效的方法是及时治疗与其发生发展相关的外阴癌前病变。, cover=https://img.medsci.cn/2022118/1642519281399_5579292.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Jan 02 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">外阴癌是一种罕见的好发于绝经后女性的生殖系统恶性肿瘤。目前并未有针对外阴癌的特别筛查方法,降低其发生率最有效的方法是及时治疗与其发生发展相关的外阴癌前病变。虽然外阴癌可以无症状,但大多数患者会出现外阴瘙痒或疼痛,发现外阴肿块或溃疡。</span></p>, tagList=[TagDto(tagId=1983, tagName=妇科肿瘤), TagDto(tagId=39029, tagName=外阴癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=116777, appHits=102, showAppHits=0, pcHits=885, showPcHits=116674, likes=0, shares=25, comments=5, approvalStatus=1, publishedTime=Tue Jan 18 23:19:58 CST 2022, publishedTimeString=2022-01-02, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Jan 18 23:23:34 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 06:58:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《FIGO 2021癌症报告》——外阴癌诊治指南解读.pdf)])
《FIGO 2021癌症报告》——外阴癌诊治指南解读.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2142343, encodeId=54202142343ba, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d828744728, createdName=ms2000001737718687, createdTime=Mon Jun 12 10:56:40 CST 2023, time=2023-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203843, encodeId=8a9412038435e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/K6v7bVicvYokwtCMPpNzqDoC6Bia9vZE9T1FvibSUxDibM9w7GbDnpBKXLQZaibqPRGY2Nz43WulofLkgz1cffbb3Zg/132, createdBy=bb8c2522602, createdName=www810910, createdTime=Fri Mar 18 16:44:58 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186309, encodeId=419d11863092c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ffa6421348, createdName=ms9000001400019155, createdTime=Thu Jan 20 08:10:10 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185869, encodeId=98361185869e3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 19 07:28:41 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2023-06-12 ms2000001737718687

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2142343, encodeId=54202142343ba, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d828744728, createdName=ms2000001737718687, createdTime=Mon Jun 12 10:56:40 CST 2023, time=2023-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203843, encodeId=8a9412038435e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/K6v7bVicvYokwtCMPpNzqDoC6Bia9vZE9T1FvibSUxDibM9w7GbDnpBKXLQZaibqPRGY2Nz43WulofLkgz1cffbb3Zg/132, createdBy=bb8c2522602, createdName=www810910, createdTime=Fri Mar 18 16:44:58 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186309, encodeId=419d11863092c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ffa6421348, createdName=ms9000001400019155, createdTime=Thu Jan 20 08:10:10 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185869, encodeId=98361185869e3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 19 07:28:41 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-03-18 www810910

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2142343, encodeId=54202142343ba, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d828744728, createdName=ms2000001737718687, createdTime=Mon Jun 12 10:56:40 CST 2023, time=2023-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203843, encodeId=8a9412038435e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/K6v7bVicvYokwtCMPpNzqDoC6Bia9vZE9T1FvibSUxDibM9w7GbDnpBKXLQZaibqPRGY2Nz43WulofLkgz1cffbb3Zg/132, createdBy=bb8c2522602, createdName=www810910, createdTime=Fri Mar 18 16:44:58 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186309, encodeId=419d11863092c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ffa6421348, createdName=ms9000001400019155, createdTime=Thu Jan 20 08:10:10 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185869, encodeId=98361185869e3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 19 07:28:41 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-20 ms9000001400019155

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2142343, encodeId=54202142343ba, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d828744728, createdName=ms2000001737718687, createdTime=Mon Jun 12 10:56:40 CST 2023, time=2023-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203843, encodeId=8a9412038435e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/K6v7bVicvYokwtCMPpNzqDoC6Bia9vZE9T1FvibSUxDibM9w7GbDnpBKXLQZaibqPRGY2Nz43WulofLkgz1cffbb3Zg/132, createdBy=bb8c2522602, createdName=www810910, createdTime=Fri Mar 18 16:44:58 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186309, encodeId=419d11863092c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ffa6421348, createdName=ms9000001400019155, createdTime=Thu Jan 20 08:10:10 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185869, encodeId=98361185869e3, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 19 07:28:41 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-19 微探

    学习学习

    0

相关指南

2021 ESMO 临床实践指南中新诊断的卵巢上皮癌的更新治疗建议

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2021-07-19

子宫颈原位腺癌诊断与管理的中国专家共识（2021年版）

中国医师协会妇产科医师分会妇科肿瘤专业委员会(学组) · 2021-12-02

美国妇科肿瘤学会宫颈原位腺癌诊断治疗指南解读

暂未更新 · 2021-11-05

2021 ISGE指南：宫腔镜子宫肌瘤切除术

国际妇科内镜学会(ISGE,International Society for Gynecologic Endoscopy) · 2021-12-01

子宫内膜癌分子检测中国专家共识（2021年版）

中国抗癌协会妇科肿瘤专业委员会 · 2021-11-30

2021 中国专家共识：复发性宫颈癌¹²⁵I粒子植入治疗

中国肿瘤科相关专家小组（统称） · 2021-11-09